Chengdu huasun technology group Inc. , LTD. (SHE:000790)
China · Delayed Price · Currency is CNY 4.000
+0.090 (2.30%)
Feb 4, 2026, 3:04 PM CST
SHE:000790 Revenue
Chengdu huasun technology group Inc. , LTD. had revenue of 165.70M CNY in the quarter ending September 30, 2025, a decrease of -19.26%. This brings the company's revenue in the last twelve months to 658.28M, down -33.77% year-over-year. In the year 2024, Chengdu huasun technology group Inc. , LTD. had annual revenue of 863.98M, down -13.89%.
Revenue (ttm)
658.28M
Revenue Growth
-33.77%
P/S Ratio
3.70
Revenue / Employee
717.08K
Employees
918
Market Cap
2.44B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 863.98M | -139.40M | -13.89% |
| Dec 31, 2023 | 1.00B | 130.27M | 14.92% |
| Jan 1, 2023 | 873.10M | -81.58M | -8.55% |
| Jan 1, 2022 | 954.69M | 195.38M | 25.73% |
| Dec 31, 2020 | 759.31M | 13.97M | 1.87% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Anhui Fengyuan Pharmaceutical | 4.15B |
| Hainan Huluwa Pharmaceutical Group | 1.06B |
| Enwei Pharmaceutical | 888.64M |
| ShanXi C&Y Pharmaceutical Group Co.,LTD. | 849.26M |
| Ginwa Enterprise (Group) | 550.44M |
| Shaanxi Kanghui Pharmaceutical | 513.23M |
| Zhejiang Shapuaisi Pharmaceutical | 475.19M |
| Anhui Huangshan Capsule | 471.08M |